Serum Na-Cl value from routine blood tests reflects CO2 retention in amyotrophic lateral sclerosis
PLOS One · 2026
DOI: 10.1371/journal.pone.0358772 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Isamu Yamakawa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Shiga University of Medical Science, Otsu, Shiga, Japan. Hauptthemen laut MEDLINE: Carbon Dioxide, Amyotrophic Lateral Sclerosis, Sodium, Chlorides. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shiga University of Medical Science.
Abstract (Originalsprache)
Background
Respiratory failure is the leading cause of death in amyotrophic lateral sclerosis (ALS). Early detection of CO 2 retention is crucial for assessing respiratory failure severity and guiding noninvasive positive pressure ventilation (NPPV) management. However, arterial blood gas analysis is invasive and uncomfortable for routine monitoring.
Objective
We investigated whether the serum sodium-chloride difference (Na-Cl value), calculated from routine blood tests, could serve as a screening marker for CO 2 retention in ALS patients.
Methods
This retrospective study included 88 ALS patients with 116 paired samples of arterial blood gas and serum electrolyte data. We analyzed correlations between Na-Cl value and blood gas parameters (HCO 3 − , PCO 2 ), performed receiver operating characteristic (ROC) analysis for detecting CO 2 retention (PCO 2 ≥ 45 mmHg), and examined relationships with respiratory function (%FVC).
Results
Na-Cl value showed strong correlation with HCO 3 − (r = 0.78, p < 0.001) and PCO 2 (r = 0.71, p < 0.001). Na-Cl ≥ 37 mEq/L demonstrated sensitivity of 85.11% and specificity of 69.57% for detecting PCO 2 ≥ 45 mmHg, with negative predictive value of 87.27% (AUC = 0.842). Na-Cl ≥ 39 mEq/L achieved specificity of 92.75%. Patients with %FVC < 50% had significantly higher Na-Cl, PCO 2 , and HCO 3 − values.
Conclusions
Serum Na-Cl value serves as a simple, noninvasive screening marker for CO 2 retention in ALS. Na-Cl ≥ 37 mEq/L warrants blood gas analysis, while Na-Cl ≥ 39 mEq/L provides specificity >90%. This marker can be calculated from routine blood tests without additional cost, making it suitable for frequent monitoring and reducing the risk of missing intervention timing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Shiga University of Medical Science, Otsu, Shiga, Japan.
ORCID-Profile: Isamu Yamakawa, Makoto Urushitani
Förderung
- Shiga University of Medical Science
Zitieren
APA
Yamakawa, I., Tamura, R., Yabata, H., Tsukamoto, T., Kobashi, S., Tamaki, Y., Ogawa, N., Kitamura, A., & Urushitani, M. (2026). Serum Na-Cl value from routine blood tests reflects CO2 retention in amyotrophic lateral sclerosis. PLOS One. https://doi.org/10.1371/journal.pone.0358772
Vancouver
Yamakawa I, Tamura R, Yabata H, Tsukamoto T, Kobashi S, Tamaki Y, et al. Serum Na-Cl value from routine blood tests reflects CO2 retention in amyotrophic lateral sclerosis. PLOS One. 2026. doi:10.1371/journal.pone.0358772
BibTeX
@article{Yamakawa2026,
author = {Yamakawa, Isamu and Tamura, Ryota and Yabata, Hiroyuki and Tsukamoto, Takahito and Kobashi, Shuhei and Tamaki, Yoshitaka and Ogawa, Nobuhiro and Kitamura, Akihiro and Urushitani, Makoto},
title = {Serum Na-Cl value from routine blood tests reflects CO2 retention in amyotrophic lateral sclerosis},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0358772}
}
EUVIMED